Alpha Tau Medical Ltd. (DRTS)
NASDAQ: DRTS · Real-Time Price · USD
10.88
-0.29 (-2.60%)
At close: Jun 26, 2026, 4:00 PM EDT
10.90
+0.02 (0.18%)
After-hours: Jun 26, 2026, 7:55 PM EDT
Alpha Tau Medical Stock Forecast
Stock Price Forecast
The 5 analysts with 12-month price forecasts for Alpha Tau Medical stock have an average target of 12.6, with a low estimate of 8.00 and a high estimate of 17. The average target predicts an increase of 15.81% from the current stock price of 10.88.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Alpha Tau Medical stock from 5 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Buy | 1 | 1 | 0 | 0 | 1 | 1 |
| Hold | 0 | 0 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 4 | 4 | 5 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $15 | Buy | Reiterates | $15 | +37.87% | Jun 15, 2026 |
| Barclays | Barclays | Buy Maintains $15 → $17 | Buy | Maintains | $15 → $17 | +56.25% | Jun 4, 2026 |
| Piper Sandler | Piper Sandler | Hold Reiterates $5 → $8 | Hold | Reiterates | $5 → $8 | -26.47% | May 19, 2026 |
| Ladenburg Thalmann & Co. | Ladenburg Thalmann & Co. | Buy Reiterates $14 | Buy | Reiterates | $14 | +28.68% | May 12, 2026 |
| Citi | Citi | Buy Reiterates $7 → $9 | Buy | Reiterates | $7 → $9 | -17.28% | Mar 11, 2026 |
Financial Forecast
Revenue This Year
1.63M
Revenue Next Year
12.38M
from 1.63M
Increased by 658.10%
EPS This Year
-0.66
from -0.53
EPS Next Year
-0.51
from -0.66
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 3.2M | 29.4M | |
| Avg | 1.6M | 12.4M | |
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2027 | 2028 |
|---|---|---|
| High | 1,699.6% | 774.9% |
| Avg | 658.1% | 488.7% |
| Low | -100.0% | 201.6% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -0.61 | -0.44 | |
| Avg | -0.66 | -0.51 | |
| Low | -0.69 | -0.58 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.